BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6991941)

  • 21. Selected applications of methotrexate alone and in combination in osteosarcoma.
    Pratt CB
    Cancer Treat Rep; 1981; 65 Suppl 1():107-11. PubMed ID: 6976828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective evaluation of rotating chemotherapy in advanced breast cancer. An Eastern Cooperative Oncology Group Trial.
    Tormey D; Gelman R; Falkson G
    Am J Clin Oncol; 1983 Feb; 6(1):1-18. PubMed ID: 6340458
    [No Abstract]   [Full Text] [Related]  

  • 23. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO III and IV) as measured by surgical end-staging (second-look surgery)--the mount sinai experience.
    Cohen CJ; Bruckner HW; Goldberg JD; Holland JF
    Clin Obstet Gynaecol; 1983 Aug; 10(2):307-24. PubMed ID: 6413114
    [No Abstract]   [Full Text] [Related]  

  • 24. Six-drug combination chemotherapy for nonresectable bronchogenic carcinoma.
    Miller CF; Weltz MD; Heim WJ; Blom J
    Cancer Treat Rep; 1979 Aug; 63(8):1351-3. PubMed ID: 113094
    [No Abstract]   [Full Text] [Related]  

  • 25. [Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
    Hofmann W; Langkopf B
    Z Urol Nephrol; 1982 Dec; 75(12):889-95. PubMed ID: 6819737
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bone metastasis of breast cancer. Apropos of a series of 50 cases].
    Vincent-Joyeux F; Bontoux D; Alcalay M; Daban A; Vincent D
    Sem Hop; 1982 Dec; 58(48):2827-31. PubMed ID: 6302849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination chemotherapy in the treatment of adenocarcinoma of unknown primary origin.
    Walach N; Horn Y
    Cancer Treat Rep; 1987 Jun; 71(6):605-7. PubMed ID: 3581098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy].
    Watanabe Y; Sato H; Iida S; Yamada T; Kobayashi H; Kimoto H; Tsunamura Y; Ichihashi T; Shimizu J; Hashizume Y
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):21-35. PubMed ID: 2981515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immediate versus postponed combination chemotherapy (CAMP) for unresectable non-small cell lung cancer: a randomized trial.
    Lad TE; Nelson RB; Diekamp U; Kukla LJ; Sarma PR; Larson CS; Currie ET; Chawla MS; Tichler T; Zawila P; McGuire WP
    Cancer Treat Rep; 1981; 65(11-12):973-8. PubMed ID: 7028259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adriamycin, mitomycin C, and 5-fluorouracil in combination for advanced colorectal adenocarcinoma previously treated with 5-fluorouracil.
    Kessinger MA; Foley JF; Lemon HM
    Cancer Clin Trials; 1979; 2(4):317-9. PubMed ID: 394867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
    Cowan K; Lippman M
    Arch Intern Med; 1981 Jul; 141(8):1055-9. PubMed ID: 7018440
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of the effectiveness of 2-drug and multi-drug chemotherapy in primary lung cancer].
    Durda M; Skublewski A; Patyra R; Ziemecka E
    Pneumonol Pol; 1979; 47(7-8):603-7. PubMed ID: 231773
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemotherapy of hormonally unresponsive prostatic carcinoma.
    deKernion JB; Lindner A
    Urol Clin North Am; 1984 May; 11(2):319-26. PubMed ID: 6233779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chemotherapy in advanced cancer of the lung].
    Fleischer I; Wainstein R; Jovtis SL; Gibson AM; Barousse AP
    Medicina (B Aires); 1979; 39(4):472-6. PubMed ID: 545078
    [No Abstract]   [Full Text] [Related]  

  • 35. Combined 5-fluorouracil, adriamycin and mitomycin C in the management of adenocarcinoma metastasizing to the liver from an unknown primary site.
    al-Idrissi HY
    J Int Med Res; 1990; 18(5):425-9. PubMed ID: 2124191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclophosphamide, doxorubicin hydrochloride and 5-fluorouracil in advanced carcinoma of the prostate.
    Soloway MS; Shippel RM; Ikard M
    J Urol; 1979 Nov; 122(5):637-9. PubMed ID: 501816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy for adenocarcinoma of the lung.
    Butler TP; MacDonald JS; Smith FP; Smith LF; Woolley PV; Schein PS
    Cancer; 1979 Apr; 43(4):1183-8. PubMed ID: 445320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intra-arterial cancer chemotherapy with combined anticancer agents.
    Fujimoto S; Miyoshi T; Nomura Y; Akao T; Ito B
    Jpn J Surg; 1973 Mar; 3(1):32-9. PubMed ID: 4803900
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemotherapy of extensive large cell and adenocarcinoma of the lung: a randomized trial in 210 patients.
    Vincent RG; Mehta CR; Tucker RD; Mountain CF; Cohen M; Wilson HE; Vogel C
    Cancer; 1980 Jul; 46(2):256-60. PubMed ID: 6992978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Progress in chemotherapy of lung neoplasms].
    Niitani H
    Nihon Rinsho; 1975 May; 33(5):1833-9. PubMed ID: 1171278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.